Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 143


Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates.

He K, Li Y, Zhu J, Liu H, Lee JE, Amos CI, Hyslop T, Jin J, Lin H, Wei Q, Li Y.

Bioinformatics. 2015 Sep 17. pii: btv517. [Epub ahead of print]


Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.

Goodman CR, Sato T, Peck AR, Girondo MA, Yang N, Liu C, Yanac AF, Kovatich AJ, Hooke JA, Shriver CD, Mitchell EP, Hyslop T, Rui H.

Oncogene. 2015 Jun 22. doi: 10.1038/onc.2015.193. [Epub ahead of print]


Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.

Adam MA, Pura J, Goffredo P, Dinan MA, Reed SD, Scheri RP, Hyslop T, Roman SA, Sosa JA.

J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.


Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy.

Showalter TN, Hegarty SE, Rabinowitz C, Maio V, Hyslop T, Dicker AP, Louis DZ.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):752-9. doi: 10.1016/j.ijrobp.2014.11.038.


Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort.

Hegarty SE, Hyslop T, Dicker AP, Showalter TN.

PLoS One. 2015 Feb 23;10(2):e0118430. doi: 10.1371/journal.pone.0118430. eCollection 2015.


Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables.

Wang C, Civan J, Lai Y, Cristofanilli M, Hyslop T, Palazzo JP, Myers RE, Li B, Ye Z, Zhang K, Xing J, Yang H.

Cancer Causes Control. 2015 Jan;26(1):45-56. doi: 10.1007/s10552-014-0481-4. Epub 2014 Oct 31.


Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years.

Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, Scheri RP, Roman SA, Sosa JA.

J Clin Endocrinol Metab. 2015 Jan;100(1):115-21. doi: 10.1210/jc.2014-3039.


The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer.

Wilson C, Lin JE, Li P, Snook AE, Gong J, Sato T, Liu C, Girondo MA, Rui H, Hyslop T, Waldman SA.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2328-37. doi: 10.1158/1055-9965.EPI-14-0440. Epub 2014 Oct 10.


Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

Lai Y, Palazzo JP, Cristofanilli M, Hyslop T, Civan J, Avery T, Myers RE, Li B, Ye Z, Xing J, Yang H.

Breast Cancer Res Treat. 2014 Nov;148(1):175-85. doi: 10.1007/s10549-014-3152-y. Epub 2014 Sep 27.


Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests.

Zhang K, Lai Y, Axelrod R, Campling B, Hyslop T, Civan J, Solomides C, Myers RE, Lu B, Bar Ad V, Li B, Ye Z, Yang H.

Int J Cancer. 2015 Jan 15;136(2):382-91. doi: 10.1002/ijc.28995. Epub 2014 Jun 5.


Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.

Crandley EF, Hegarty SE, Hyslop T, Wilson DD, Dicker AP, Showalter TN.

Cancer Med. 2014 Apr;3(2):397-405. doi: 10.1002/cam4.205. Epub 2014 Feb 12.


Pain characteristics and age-related pain trajectories in infants and young children with sickle cell disease.

Dampier C, Ely B, Brodecki D, Coleman C, Aertker L, Sendecki JA, Leiby B, Kesler K, Hyslop T, Stuart M.

Pediatr Blood Cancer. 2014 Feb;61(2):291-6. doi: 10.1002/pbc.24796. Epub 2013 Sep 24.


Overexpressing TNF-alpha in pancreatic ductal adenocarcinoma cells and fibroblasts modifies cell survival and reduces fatty acid synthesis via downregulation of sterol regulatory element binding protein-1 and activation of acetyl CoA carboxylase.

Al-Zoubi M, Chipitsyna G, Saxena S, Sarosiek K, Gandhi A, Kang CY, Relles D, Andrelsendecki J, Hyslop T, Yeo CJ, Arafat HA.

J Gastrointest Surg. 2014 Feb;18(2):257-68; discussion 268. doi: 10.1007/s11605-013-2370-7. Epub 2013 Oct 4.


Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.

Mishra MV, Scher ED, Andrel J, Margules AC, Hegarty SE, Trabulsi EJ, Hyslop T, Den RB, Lallas CD, Gomella LG, Dicker AP, Showalter TN.

Am J Clin Oncol. 2015 Feb;38(1):55-60. doi: 10.1097/COC.0b013e318287bb6b.


Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.

Yang N, Liu C, Peck AR, Girondo MA, Yanac AF, Tran TH, Utama FE, Tanaka T, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Rui H.

Breast Cancer Res. 2013;15(5):R73.


Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Kang CY, Wang J, Axell-House D, Soni P, Chu ML, Chipitsyna G, Sarosiek K, Sendecki J, Hyslop T, Al-Zoubi M, Yeo CJ, Arafat HA.

J Gastrointest Surg. 2014 Jan;18(1):7-15. doi: 10.1007/s11605-013-2326-y. Epub 2013 Sep 4.


Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.

Sato T, Tran TH, Peck AR, Girondo MA, Liu C, Goodman CR, Neilson LM, Freydin B, Chervoneva I, Hyslop T, Kovatich AJ, Hooke JA, Shriver CD, Fuchs SY, Rui H.

Oncogene. 2014 Apr 24;33(17):2215-24. doi: 10.1038/onc.2013.172. Epub 2013 May 27.


Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients.

Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D, Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H.

J Gastrointest Cancer. 2013 Sep;44(3):293-304. doi: 10.1007/s12029-013-9491-9.


Molecular staging of node negative patients with colorectal cancer.

Hyslop T, Waldman SA.

J Cancer. 2013;4(3):193-9. doi: 10.7150/jca.5830. Epub 2013 Mar 1.


Guanylyl cyclase C as a biomarker in colorectal cancer.

Hyslop T, Waldman SA.

Biomark Med. 2013 Feb;7(1):159-67. doi: 10.2217/bmm.12.90. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk